11/14/2024
3:53 PM | Aprea Therapeutics (Subject)
Nantahala Capital Management, LLC (Filed by)
| Form SCHEDULE 13G | |
11/07/2024
7:35 AM | Aprea Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024
7:38 AM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/25/2024
4:42 PM | Aprea Therapeutics (Issuer)
Duey Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/24/2024
7:30 AM | Aprea Therapeutics (Issuer)
Gilad Oren (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2024
8:00 AM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
7:30 AM | Aprea Therapeutics (Issuer)
Duey Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
10/16/2024
7:30 AM | Aprea Therapeutics (Issuer)
Hamill John P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2024
7:30 AM | Aprea Therapeutics (Issuer)
Duey Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2024
7:31 AM | Aprea Therapeutics (Issuer)
Gilad Oren (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
7:30 AM | Aprea Therapeutics (Issuer)
Hamill John P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
7:31 AM | Aprea Therapeutics (Issuer)
Gilad Oren (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
7:31 AM | Aprea Therapeutics (Issuer)
Seizinger Bernd R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/09/2024
7:45 AM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
7:35 AM | Aprea Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/12/2024
7:40 AM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2024
3:15 PM | Aprea Therapeutics (Issuer)
Duey Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
3:16 PM | Aprea Therapeutics (Issuer)
Grissinger Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
3:17 PM | Aprea Therapeutics (Issuer)
HENNEMAN JOHN B III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
3:18 PM | Aprea Therapeutics (Issuer)
Peters Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
3:19 PM | Aprea Therapeutics (Issuer)
Pamukcu Rifat (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:15 PM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2024
7:45 AM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
7:40 AM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
7:35 AM | Aprea Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/02/2024
3:15 PM | Aprea Therapeutics (Issuer)
Mirza Nadeem Q. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/02/2024
3:16 PM | Aprea Therapeutics (Issuer)
Mirza Nadeem Q. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
6:34 AM | Aprea Therapeutics (Filer)
| Form 424B3 | |
04/29/2024
11:15 PM | Aprea Therapeutics (Filer)
| Form EFFECT | |
04/25/2024
6:30 AM | Aprea Therapeutics (Filer)
| Form ARS | |
04/25/2024
6:15 AM | Aprea Therapeutics (Filer)
| Form DEFA14A | |
04/25/2024
6:00 AM | Aprea Therapeutics (Filer)
| Form DEF 14A | |
04/10/2024
3:15 PM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
4:59 PM | Aprea Therapeutics (Issuer)
Hamill John P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
4:57 PM | Aprea Therapeutics (Issuer)
Gilad Oren (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
7:15 AM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/26/2024
6:45 AM | Aprea Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/14/2024
7:51 PM | Aprea Therapeutics (Issuer)
Gilad Oren (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2024
7:52 PM | Aprea Therapeutics (Issuer)
HENNEMAN JOHN B III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2024
7:53 PM | Aprea Therapeutics (Issuer)
Seizinger Bernd R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2024
7:54 PM | Aprea Therapeutics (Issuer)
Hamill John P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Most People Are Dead Wrong. (Ad) Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines about artificial intelligence.
Everyone's talking about AI right now.
But see, I've been talking about it for years. I call it my AI Retirement Playbook. I recommend you check it out now. |
03/12/2024
3:31 PM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
7:00 AM | Aprea Therapeutics (Subject)
Sio Capital Management, LLC (Filed by)
| Form SC 13G | |
02/07/2024
5:55 PM | Aprea Therapeutics (Subject)
HIRSCHMAN ORIN (Filed by)
| Form SC 13G/A | |
02/06/2024
4:01 PM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/04/2024
11:15 PM | Aprea Therapeutics (Filer)
| Form EFFECT | |
01/26/2024
6:13 AM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/26/2024
5:03 AM | Aprea Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
01/04/2024
3:16 PM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
